From
To
Hone Health reports that 50% of peptide users mistakenly believe they take FDA-approved compounds, highlighting risks of using unregulated peptides.
Ivim Health reports that peptide therapies, spurred by GLP-1 interest, require careful understanding and medical oversight for safe use.